Allspring Global Investments’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $606K | Buy |
73,754
+13,187
| +22% | +$108K | ﹤0.01% | 1288 |
|
|
2025
Q1 | $508K | Buy |
60,567
+21,079
| +53% | +$177K | ﹤0.01% | 1452 |
|
|
2024
Q4 | $313K | Buy |
39,488
+689
| +2% | +$5.46K | ﹤0.01% | 1569 |
|
|
2024
Q3 | $323K | Sell |
38,799
-17,152
| -31% | -$143K | ﹤0.01% | 1579 |
|
|
2024
Q2 | $355K | Sell |
55,951
-73,201
| -57% | -$465K | ﹤0.01% | 1584 |
|
|
2024
Q1 | $783K | Sell |
129,152
-8,612
| -6% | -$52.2K | ﹤0.01% | 1426 |
|
|
2023
Q4 | $836K | Sell |
137,764
-146,925
| -52% | -$892K | ﹤0.01% | 1380 |
|
|
2023
Q3 | $1.2M | Sell |
284,689
-340,790
| -54% | -$1.44M | ﹤0.01% | 1321 |
|
|
2023
Q2 | $1.94M | Sell |
625,479
-1,283,443
| -67% | -$3.98M | ﹤0.01% | 1246 |
|
|
2023
Q1 | $2.65M | Buy |
1,908,922
+325,553
| +21% | +$453K | ﹤0.01% | 1163 |
|
|
2022
Q4 | $3.15M | Buy |
1,583,369
+775,707
| +96% | +$1.54M | 0.01% | 1108 |
|
|
2022
Q3 | $1.63M | Buy |
807,662
+481,227
| +147% | +$972K | ﹤0.01% | 1297 |
|
|
2022
Q2 | $1.04M | Buy |
326,435
+1,186
| +0.4% | +$3.77K | ﹤0.01% | 1423 |
|
|
2022
Q1 | $1.36M | Sell |
325,249
-122,451
| -27% | -$511K | ﹤0.01% | 1718 |
|
|
2021
Q4 | $2.14M | Buy |
+447,700
| New | +$2.14M | ﹤0.01% | 1502 |
|